Sale of Equity Interests in Theravance Respiratory Company, LLC and Discontinued Operations - Summary financial information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Summary financial information
Revenues	$ 12,451	$ 13,194	$ 36,697	$ 40,365
Income from continuing operations	(16,023)	(55,910)	(78,568)	(207,256)
Net income	$ 916,631	(35,308)	882,494	(167,392)
TRC
Summary financial information
Income from continuing operations		35,391	71,693	80,244
Net income		35,539	62,632	79,655
TRC | Royalties
Summary financial information
Revenues		$ 35,585	$ 72,029	$ 84,055